# China NMPA Inspection - Shaanxi Bohong Biotechnology Group Co., Ltd. - July 28, 2017

Source: https://www.globalkeysolutions.net/records/china_inspection/shaanxi-bohong-biotechnology-group-co-ltd/7668c3fa-d213-4b9e-a6ed-1984d5d96b57/
Source feed: China

> China NMPA unannounced inspection for Shaanxi Bohong Biotechnology Group Co., Ltd. published July 28, 2017. This document, published by the National Medical Products Administration (NMPA) of China on July 28, 2017, serves as a formal notification concerning 

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Supervision and Inspection Report on Shaanxi Bohong Biotechnology Group Co., Ltd.
- Company Name: Shaanxi Bohong Biotechnology Group Co., Ltd.
- Publication Date: 2017-07-28
- Product Type: Drugs
- Summary: This document, published by the National Medical Products Administration (NMPA) of China on July 28, 2017, serves as a formal notification concerning a supervision and inspection conducted at Shaanxi Bohong Biotechnology Group Co., Ltd. The notice confirms that regulatory oversight activities were performed by the NMPA, indicating the company's engagement with the Chinese pharmaceutical and medical device regulatory framework. However, the provided content is strictly limited to this announcement. It does not include specific details regarding the precise dates of the inspection, any identified main violations or issues, the particular regulatory guidelines or standards that were the focus of the inspection, or any required actions or remediation plans to be undertaken by Shaanxi Bohong Biotechnology Group Co., Ltd. Consequently, a comprehensive summary detailing these crucial aspects cannot be generated solely from the information presented in this notification.

Company: https://www.globalkeysolutions.net/companies/shaanxi-bohong-biotechnology-group-co-ltd/0cc5a3d4-53c9-45ec-8561-a8b058f9c4f0/